leisure time -WSS

leisure time

author：hotspot 2025-09-30 23:19:59 - browse：13568

insulin biosimilar — The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. Jacquelyn Martin/AP

A group representing clinical labs across the country sued the Food and Drug Administration on Wednesday over the agency’s plan to actively regulate lab-developed tests.

The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. When the FDA finalized its test regulation plan last month, several experts said it was only a matter of time until someone in the lab industry sued.

Tests made in labs have historically gone unregulated by the FDA, as the agency considered them low-risk when it started regulating medical devices in 1976. But the tests have since become more numerous and complex, and the regulatory gray area enabled unreliable tests to thrive and harm patients. Infamous examples include Theranos’ blood tests, as well as misleading prenatal genetic tests from a range of companies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： CDC wastewater surveillance dashboard to track bird flu hotspots

WSS

Eisai exec who led development of Alzheimer’s drug to retire

Medicare wants to send $9 billion to 340B hospitals

Readout LOUD podcast: brain research, obesity drug sales, Novartis

H5N1 bird flu: what we're starting to learn about infection in cows

Giraffe named Twiga, who was among the oldest cared for by humans, died at age 31 at East Texas zoo

Shionogi licenses Pompe disease therapy from Maze Therapeutics

hotspot

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Wikipedia

Medicare details structure of new drug price negotiation program

Readout LOUD podcast: brain research, obesity drug sales, Novartis

Heart attack and stroke risk calculators need revising

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

Medicare details structure of new drug price negotiation program

Judge agrees to delay next hearing in Trump classified documents case

At least 13 dead in Texas as scorching temps continue

Software glitch causes Tandem insulin pump to shutdown, FDA warns

Novavax promises a turnaround & Lilly roils the obesity market

H5N1 bird flu: what we're starting to learn about infection in cows

entertainment

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

Apple Watch's A

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

Brain worms: The science behind RFK Jr.'s parasitic infection

Giraffe named Twiga, who was among the oldest cared for by humans, died at age 31 at East Texas zoo

Elevance, private equity launch primary care company

focus

entertainment

focus

entertainment